Utah Retirement Systems’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,100
Closed -$285K 988
2023
Q4
$285K Buy
5,100
+100
+2% +$5.6K ﹤0.01% 877
2023
Q3
$206K Sell
5,000
-16,901
-77% -$697K ﹤0.01% 937
2023
Q2
$1.22M Sell
21,901
-600
-3% -$33.5K 0.02% 690
2023
Q1
$1.26M Buy
22,501
+2,793
+14% +$156K 0.02% 680
2022
Q4
$718K Hold
19,708
0.01% 762
2022
Q3
$561K Buy
19,708
+100
+0.5% +$2.85K 0.01% 798
2022
Q2
$888K Buy
19,608
+2,588
+15% +$117K 0.01% 730
2022
Q1
$1.3M Buy
17,020
+1,894
+13% +$144K 0.02% 692
2021
Q4
$2.25M Buy
15,126
+1,163
+8% +$173K 0.03% 540
2021
Q3
$2.03M Buy
13,963
+100
+0.7% +$14.6K 0.03% 561
2021
Q2
$2.72M Buy
13,863
+2,763
+25% +$541K 0.03% 485
2021
Q1
$2.01M Buy
11,100
+8,100
+270% +$1.47M 0.03% 564
2020
Q4
$425K Buy
3,000
+500
+20% +$70.8K 0.01% 835
2020
Q3
$312K Buy
2,500
+200
+9% +$25K 0.01% 856
2020
Q2
$205K Buy
+2,300
New +$205K ﹤0.01% 942